Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Healthcare professionals' level of medication knowledge in Africa: a systematic review.

Berhe DF, Taxis K, Haaijer-Ruskamp FM, Mol PGM.

Br J Clin Pharmacol. 2018 Dec;84(12):2729-2746. doi: 10.1111/bcp.13746. Epub 2018 Oct 14. Review.

2.

Application of the STOPP/START criteria to a medical record database.

Nauta KJ, Groenhof F, Schuling J, Hugtenburg JG, van Hout HPJ, Haaijer-Ruskamp FM, Denig P.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1242-1247. doi: 10.1002/pds.4283. Epub 2017 Aug 11.

PMID:
28799295
3.

Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia.

Berhe DF, Taxis K, Haaijer-Ruskamp FM, Mulugeta A, Mengistu YT, Mol PGM.

BMJ Open. 2017 Aug 3;7(8):e015743. doi: 10.1136/bmjopen-2016-015743.

4.

Views of general practice staff about the use of a patient-oriented treatment decision aid in shared decision making for patients with type 2 diabetes: A mixed-methods study.

Wildeboer A, du Pon E, Schuling J, Haaijer-Ruskamp FM, Denig P.

Health Expect. 2018 Feb;21(1):64-74. doi: 10.1111/hex.12586. Epub 2017 Jun 21.

5.

Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients.

Berhe DF, Taxis K, Haaijer-Ruskamp FM, Mulugeta A, Mengistu YT, Burgerhof JGM, Mol PGM.

Br J Clin Pharmacol. 2017 Sep;83(9):2107-2117. doi: 10.1111/bcp.13312. Epub 2017 Jun 15.

6.

Outcome prioritisation tool for medication review in older patients with multimorbidity: a pilot study in general practice.

van Summeren JJ, Schuling J, Haaijer-Ruskamp FM, Denig P.

Br J Gen Pract. 2017 Jul;67(660):e501-e506. doi: 10.3399/bjgp17X690485. Epub 2017 Mar 27.

7.

Eliciting Preferences of Multimorbid Elderly Adults in Family Practice Using an Outcome Prioritization Tool.

van Summeren JJ, Haaijer-Ruskamp FM, Schuling J.

J Am Geriatr Soc. 2016 Nov;64(11):e143-e148. doi: 10.1111/jgs.14415. Epub 2016 Sep 9.

PMID:
27612181
8.

Using primary care electronic health record data for comparative effectiveness research: experience of data quality assessment and preprocessing in The Netherlands.

Huang Y, Voorham J, Haaijer-Ruskamp FM.

J Comp Eff Res. 2016 Jul;5(4):345-54. doi: 10.2217/cer-2015-0022. Epub 2016 Jun 27.

PMID:
27346480
9.

Comparing the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on renal function decline in diabetes.

Huang Y, Haaijer-Ruskamp FM, Voorham J.

J Comp Eff Res. 2016 May;5(3):229-37. doi: 10.2217/cer.15.64. Epub 2016 Apr 22.

PMID:
27102734
10.

The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.

de Vries ST, de Vries FM, Dekker T, Haaijer-Ruskamp FM, de Zeeuw D, Ranchor AV, Denig P.

PLoS One. 2015 Oct 7;10(10):e0139755. doi: 10.1371/journal.pone.0139755. eCollection 2015.

11.

Medication Errors in Vietnamese Hospitals: Prevalence, Potential Outcome and Associated Factors.

Nguyen HT, Nguyen TD, van den Heuvel ER, Haaijer-Ruskamp FM, Taxis K.

PLoS One. 2015 Sep 18;10(9):e0138284. doi: 10.1371/journal.pone.0138284. eCollection 2015.

12.

Adverse drug reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase.

Berhe DF, Juhlin K, Star K, Beyene KG, Dheda M, Haaijer-Ruskamp FM, Taxis K, Mol PG.

Trop Med Int Health. 2015 Jun;20(6):797-806. doi: 10.1111/tmi.12481. Epub 2015 Mar 18.

13.

Understanding drug preferences, different perspectives.

Mol PG, Arnardottir AH, Straus SM, de Graeff PA, Haaijer-Ruskamp FM, Quik EH, Krabbe PF, Denig P.

Br J Clin Pharmacol. 2015 Jun;79(6):978-87. doi: 10.1111/bcp.12566.

14.

Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial.

Denig P, Schuling J, Haaijer-Ruskamp F, Voorham J.

BMJ. 2014 Sep 25;349:g5651. doi: 10.1136/bmj.g5651.

15.

Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.

de Vries ST, Haaijer-Ruskamp FM, de Zeeuw D, Denig P.

Health Qual Life Outcomes. 2014 Aug 13;12:103. doi: 10.1186/s12955-014-0103-6.

16.

Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients.

Vermeulen KM, van Doormaal JE, Zaal RJ, Mol PG, Lenderink AW, Haaijer-Ruskamp FM, Kosterink JG, van den Bemt PM.

Int J Med Inform. 2014 Aug;83(8):572-80. doi: 10.1016/j.ijmedinf.2014.05.003. Epub 2014 May 23.

PMID:
24929633
17.

The validity of a patient-reported adverse drug event questionnaire using different recall periods.

de Vries ST, Haaijer-Ruskamp FM, de Zeeuw D, Denig P.

Qual Life Res. 2014 Nov;23(9):2439-45. doi: 10.1007/s11136-014-0715-7. Epub 2014 May 22.

PMID:
24848596
18.

Potential overtreatment and undertreatment of diabetes in different patient age groups in primary care after the introduction of performance measures.

de Vries ST, Voorham J, Haaijer-Ruskamp FM, Denig P.

Diabetes Care. 2014;37(5):1312-20. doi: 10.2337/dc13-1861. Epub 2014 Mar 4.

PMID:
24595634
19.

Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes.

de Vries ST, Keers JC, Visser R, de Zeeuw D, Haaijer-Ruskamp FM, Voorham J, Denig P.

J Psychosom Res. 2014 Feb;76(2):134-8. doi: 10.1016/j.jpsychores.2013.11.003. Epub 2013 Nov 13.

20.

Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review.

Huang Y, Zhou Q, Haaijer-Ruskamp FM, Postma MJ.

BMC Nephrol. 2014 Jan 15;15:15. doi: 10.1186/1471-2369-15-15. Review.

21.

Errors in preparation and administration of insulin in two urban Vietnamese hospitals: an observational study.

Nguyen HT, Nguyen TD, Haaijer-Ruskamp FM, Taxis K.

Nurs Res. 2014 Jan-Feb;63(1):68-72. doi: 10.1097/NNR.0000000000000010.

PMID:
24335915
22.

Do treatment quality indicators predict cardiovascular outcomes in patients with diabetes?

Sidorenkov G, Voorham J, de Zeeuw D, Haaijer-Ruskamp FM, Denig P.

PLoS One. 2013 Oct 30;8(10):e78821. doi: 10.1371/journal.pone.0078821. eCollection 2013.

23.

The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after study.

Nguyen HT, Pham HT, Vo DK, Nguyen TD, van den Heuvel ER, Haaijer-Ruskamp FM, Taxis K.

BMJ Qual Saf. 2014 Apr;23(4):319-24. doi: 10.1136/bmjqs-2013-002357. Epub 2013 Nov 6.

PMID:
24195894
24.

Post-approval safety issues with innovative drugs: a European cohort study.

Mol PG, Arnardottir AH, Motola D, Vrijlandt PJ, Duijnhoven RG, Haaijer-Ruskamp FM, de Graeff PA, Denig P, Straus SM.

Drug Saf. 2013 Nov;36(11):1105-15. doi: 10.1007/s40264-013-0094-y.

PMID:
24048690
25.

The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.

Piening S, de Graeff PA, Straus SM, Haaijer-Ruskamp FM, Mol PG.

Drug Saf. 2013 Sep;36(9):723-31. doi: 10.1007/s40264-013-0079-x.

PMID:
23797603
26.

Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.

de Vries ST, Mol PG, de Zeeuw D, Haaijer-Ruskamp FM, Denig P.

Drug Saf. 2013 Sep;36(9):765-77. doi: 10.1007/s40264-013-0036-8.

PMID:
23553447
27.

When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines.

Reber KC, Piening S, Wieringa JE, Straus SM, Raine JM, de Graeff PA, Haaijer-Ruskamp FM, Mol PG.

Clin Pharmacol Ther. 2013 Apr;93(4):360-5. doi: 10.1038/clpt.2012.262. Epub 2012 Dec 27.

PMID:
23443752
28.

Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT database.

Sidorenkov G, Voorham J, de Zeeuw D, Haaijer-Ruskamp FM, Denig P.

BMJ Qual Saf. 2013 Apr;22(4):339-47. doi: 10.1136/bmjqs-2012-001203. Epub 2013 Feb 5.

PMID:
23386729
29.

Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohort.

Sidorenkov G, Voorham J, Haaijer-Ruskamp FM, de Zeeuw D, Denig P.

Med Care. 2013 Feb;51(2):172-9. doi: 10.1097/MLR.0b013e318277eaf5.

PMID:
23222526
30.
31.

Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands.

Piening S, Haaijer-Ruskamp FM, de Graeff PA, Straus SM, Mol PG.

Drug Saf. 2012 Nov 1;35(11):1061-72. doi: 10.2165/11635750-000000000-00000.

PMID:
23061782
32.

Indicators of quality use of medicines in South-East Asian countries: a systematic review.

Nguyen HT, Wirtz VJ, Haaijer-Ruskamp FM, Taxis K.

Trop Med Int Health. 2012 Dec;17(12):1552-66. doi: 10.1111/j.1365-3156.2012.03081.x. Epub 2012 Sep 14. Review.

33.

A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators.

Martirosyan L, Markhorst J, Denig P, Haaijer-Ruskamp FM, Braspenning J.

BMC Health Serv Res. 2012 Jul 7;12:191. doi: 10.1186/1472-6963-12-191.

34.

Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study.

Schuling J, Gebben H, Veehof LJ, Haaijer-Ruskamp FM.

BMC Fam Pract. 2012 Jul 9;13:56. doi: 10.1186/1471-2296-13-56.

35.

Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort study.

Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, de Zeeuw D, Stolk RP, Denig P.

PLoS One. 2012;7(6):e38707. doi: 10.1371/journal.pone.0038707. Epub 2012 Jun 5.

36.

Impact of safety-related regulatory action on clinical practice: a systematic review.

Piening S, Haaijer-Ruskamp FM, de Vries JT, van der Elst ME, de Graeff PA, Straus SM, Mol PG.

Drug Saf. 2012 May 1;35(5):373-85. doi: 10.2165/11599100-000000000-00000. Review.

PMID:
22480319
37.

Impact of safety-related regulatory action on drug use in ambulatory care in the Netherlands.

Piening S, Reber KC, Wieringa JE, Straus SM, de Graeff PA, Haaijer-Ruskamp FM, Mol PG.

Clin Pharmacol Ther. 2012 May;91(5):838-45. doi: 10.1038/clpt.2011.308.

PMID:
22472991
38.

Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post-hoc analysis of observational studies published between 1999 and 2011.

Hakobyan L, Haaijer-Ruskamp FM, de Zeeuw D, Dobre D, Denig P.

Drug Saf. 2011 Dec 1;34(12):1191-202. doi: 10.2165/11593810-000000000-00000.

PMID:
22077507
39.

Development of a minimal set of prescribing quality indicators for diabetes management on a general practice level.

Martirosyan L, Haaijer-Ruskamp FM, Braspenning J, Denig P.

Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1053-9. doi: 10.1002/pds.2248. Epub 2011 Oct 14.

PMID:
22002240
40.

Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.

Arnardottir AH, Haaijer-Ruskamp FM, Straus SM, de Graeff PA, Mol PG.

Drug Saf. 2011 Nov 1;34(11):1101-14. doi: 10.2165/11592060-000000000-00000.

PMID:
21981437
41.

Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.

Dequito AB, Mol PG, van Doormaal JE, Zaal RJ, van den Bemt PM, Haaijer-Ruskamp FM, Kosterink JG.

Drug Saf. 2011 Nov 1;34(11):1089-100. doi: 10.2165/11592030-000000000-00000.

PMID:
21981436
42.

A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.

Hakobyan L, Haaijer-Ruskamp FM, de Zeeuw D, Dobre D, Denig P.

Health Qual Life Outcomes. 2011 Sep 29;9:83. doi: 10.1186/1477-7525-9-83. Review.

43.

A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness.

Sidorenkov G, Haaijer-Ruskamp FM, de Zeeuw D, Denig P.

PLoS One. 2011;6(9):e24278. doi: 10.1371/journal.pone.0024278. Epub 2011 Sep 8.

44.

Coping with adverse drug events in patients with heart failure: Exploring the role of medication beliefs and perceptions.

De Smedt RH, Jaarsma T, Ranchor AV, van der Meer K, Groenier KH, Haaijer-Ruskamp FM, Denig P.

Psychol Health. 2012;27(5):570-87. doi: 10.1080/08870446.2011.605886. Epub 2011 Aug 9.

PMID:
21827288
45.

Self-reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: A cross-sectional survey.

De Smedt RH, Denig P, van der Meer K, Haaijer-Ruskamp FM, Jaarsma T.

Int J Nurs Stud. 2011 Dec;48(12):1540-50. doi: 10.1016/j.ijnurstu.2011.05.014. Epub 2011 Jul 19.

PMID:
21774932
46.

Do we need individualised prescribing quality assessment? The case of diabetes treatment.

Denig P, Haaijer-Ruskamp F.

Int J Clin Pharm. 2011 Apr;33(2):145-9. doi: 10.1007/s11096-010-9471-0.

PMID:
21744186
47.

Review: relation between quality-of-care indicators for diabetes and patient outcomes: a systematic literature review.

Sidorenkov G, Haaijer-Ruskamp FM, de Zeeuw D, Bilo H, Denig P.

Med Care Res Rev. 2011 Jun;68(3):263-89. doi: 10.1177/1077558710394200. Epub 2011 May 2. Review.

PMID:
21536606
48.

Additional safety risk to exceptionally approved drugs in Europe?

Arnardottir AH, Haaijer-Ruskamp FM, Straus SM, Eichler HG, de Graeff PA, Mol PG.

Br J Clin Pharmacol. 2011 Sep;72(3):490-9. doi: 10.1111/j.1365-2125.2011.03995.x.

49.

Medication adherence affects treatment modifications in patients with type 2 diabetes.

Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, Stolk RP, Denig P; Groningen Initiative to Analyze Type 2 Diabetes Treatment Group.

Clin Ther. 2011 Jan;33(1):121-34. doi: 10.1016/j.clinthera.2011.01.024.

50.

Perceived adverse drug events in heart failure: patients' perception and related factors.

De Smedt RH, Haaijer-Ruskamp FM, Groenier KH, van der Meer K, Jaarsma T.

J Cardiovasc Nurs. 2011 May-Jun;26(3):250-60. doi: 10.1097/JCN.0b013e318200ed94.

PMID:
21263347

Supplemental Content

Loading ...
Support Center